Recombinant Human cytomegalovirus Uncharacterized protein HVLF4 (US14) is a transmembrane protein encoded by the US14 gene of Human Cytomegalovirus (HCMV) strain AD169, a β-herpesvirus. This protein is produced via in vitro expression in E. coli systems and serves as a research tool for studying HCMV pathogenesis and immune evasion mechanisms .
| Property | Detail |
|---|---|
| Molecular Weight | ~35 kDa (predicted) |
| Storage Conditions | -20°C (short-term); -80°C (long-term) |
| Purity | Full-length protein, confirmed by SDS-PAGE |
| Tag | N-terminal 10xHis |
Antigen production: Used to generate antibodies for serological assays .
Structural studies: Characterization of transmembrane domains and post-translational modifications .
Vaccine development: Comparative studies with attenuated HCMV strains (e.g., Towne/Toledo chimeras) .
Low immunogenicity: Limited antibody detection in clinical sera compared to immunodominant HCMV proteins (e.g., UL144) .
Functional redundancy: Overlapping roles with other HCMV immune evasion genes (e.g., US11, UL144) .
While US14 itself is not directly linked to clinical outcomes, HCMV genotypes in the UL/b' region (e.g., UL144) correlate with:
US14 resides in a genomic region prone to recombination, contributing to HCMV's high genetic diversity . Comparative studies show:
Geographical variation: African vs. European strain divergence in conserved regions .
Balancing selection: Maintenance of immunomodulatory allele diversity across populations .
Stability: Avoid repeated freeze-thaw cycles; aliquot working stocks .
Detection: Western blotting recommended due to intracellular retention .
US14 is a protein encoded within the unique short (US) region of the human cytomegalovirus genome. Like many HCMV proteins, US14 remains largely uncharacterized despite HCMV having the largest genome amongst human herpesviruses (~236 kb with approximately 180 genes) . The protein belongs to the US12 gene family, which includes a set of related proteins (US12-US21) that share structural similarities. Based on sequence analysis, US14 is predicted to be a multi-pass transmembrane protein with potential roles in immune evasion or viral replication.
US14 expression patterns vary across the viral replication cycle. While detailed temporal expression data specifically for US14 is limited, most HCMV genes follow characteristic temporal expression patterns (immediate-early, early, and late). Understanding when US14 is expressed can provide crucial clues about its function.
Methodological approach: To characterize US14 expression kinetics, researchers should perform time-course experiments using quantitative PCR and western blotting after infection of permissive cell types. Inhibitors of viral DNA replication (like foscarnet) can help determine if US14 is an early or late gene. Additionally, analyzing US14 expression in different cell types is important since HCMV permissiveness varies significantly based on cell differentiation state .
Producing functional recombinant US14 presents challenges due to its predicted transmembrane domains. Several expression systems have relative advantages depending on research objectives.
Methodological approach: For structural studies, bacterial systems (E. coli) with fusion tags (His, GST, MBP) can produce protein fragments, though full-length expression may require eukaryotic systems. Baculovirus-insect cell systems often provide better yields for membrane proteins while maintaining proper folding. Mammalian expression systems (typically HEK293 or CHO cells) offer the most authentic post-translational modifications but with potentially lower yields. When designing expression constructs, consider epitope tags that don't interfere with protein function and codon optimization for the host system.
Selecting appropriate cell models is critical for US14 functional studies, as HCMV exhibits strict cell tropism and differential gene expression patterns across cell types.
Methodological approach: Primary human fibroblasts (MRC-5, WI-38) represent the gold standard for HCMV replication studies. For immune interaction studies, models should include monocyte/macrophage lineages, as these represent important sites of HCMV latency . When investigating US14 in isolation (outside the context of viral infection), researchers should compare results across multiple cell types, including epithelial cells (ARPE-19), endothelial cells, and cells of myeloid origin. Similar to approaches used for US27 , proximity ligation assays (PLA) can detect protein-protein interactions involving US14, potentially identifying binding partners that could reveal function.
Understanding where US14 localizes within infected cells provides important functional insights.
Methodological approach: Researchers should employ complementary approaches:
Immunofluorescence microscopy with antibodies against US14 or epitope-tagged versions
Subcellular fractionation followed by western blotting
Live-cell imaging using fluorescent protein fusions (if function is preserved)
Electron microscopy for high-resolution localization
Co-localization studies with cellular organelle markers (ER, Golgi, endosomes, plasma membrane) are essential. For trafficking studies, techniques used to study other viral transmembrane proteins like US27, which exhibits "punctate and perinuclear localization" , may be adapted for US14.
CRISPR-Cas9 gene editing provides powerful approaches for investigating US14 function within the viral genome context.
Methodological approach: Researchers can employ several strategies:
Generate US14-knockout HCMV strains using CRISPR-Cas9 editing of viral bacterial artificial chromosomes (BACs)
Create US14 mutants with specific domain deletions or point mutations
Implement CRISPR activation or interference systems to modulate US14 expression
Perform CRISPR screens to identify host factors interacting with US14
When designing guide RNAs, researchers should carefully analyze the US14 locus to avoid disrupting overlapping genes or regulatory elements. Phenotypic comparisons between wild-type and US14-mutant viruses should include growth curve analysis, cell tropism assessment, and immune evasion function testing.
Many HCMV US region proteins function in immune evasion, suggesting US14 may play a similar role. HCMV dedicates a significant portion of its genome to immune modulation, with viral strategies targeting both innate and adaptive responses.
Methodological approach: Researchers should investigate whether US14 affects:
Antigen presentation (MHC-I or MHC-II pathways)
Natural killer cell recognition
Cytokine signaling
Pattern recognition receptor pathways
Experimental systems should compare wild-type virus with US14-deletion mutants, examining immune recognition outcomes. Additionally, single-expression systems can determine if US14 alone is sufficient for specific immune evasion phenotypes. Analysis should include quantitative measurements of surface MHC molecules, cytokine production, and immune cell activation markers.
Understanding the interaction network of US14 would provide significant insights into its function. Similar to how "CXCR4, IL-10R, and US27 form a novel virus-host signaling complex" , US14 may participate in multiprotein complexes.
Methodological approach: Several complementary techniques should be employed:
Co-immunoprecipitation (co-IP) followed by mass spectrometry
Yeast two-hybrid screening
Proximity labeling (BioID, APEX) in infected cells
Proximity ligation assay (PLA) for candidate interactions
FRET or BRET to confirm direct interactions
Table 1: Comparison of Protein Interaction Detection Methods for US14 Research
| Method | Advantages | Limitations | Sample Preparation Requirements |
|---|---|---|---|
| Co-immunoprecipitation | Detects native complexes | May miss transient interactions | Requires specific antibodies or epitope tags |
| Proximity Ligation Assay | Visualizes interactions in situ | Requires candidate knowledge | Fixed cells with validated antibodies |
| BioID/APEX | Identifies proximal proteins | May label non-interacting proteins | Expression of fusion proteins |
| Yeast Two-Hybrid | Systematic screening capability | High false positive rate | Library construction and screening |
| FRET/BRET | Confirms direct interactions | Requires fluorescent tagging | Live cells expressing fusion proteins |
HCMV exhibits significant strain variation, which may impact US14 function and contribute to differential virulence. Previous studies have shown that "25% [of infected individuals] shared a single common strain" , highlighting the existence of predominant viral variants.
Methodological approach: Researchers should:
Sequence US14 from diverse clinical isolates (blood, urine, saliva samples)
Perform phylogenetic analysis to identify conserved and variable regions
Generate chimeric viruses with US14 variants from different strains
Test phenotypic differences in replication and immune evasion
Consider the impact of US14 variation in different tissue contexts
Analysis should focus on correlating specific sequence variations with functional outcomes, possibly revealing structure-function relationships.
Methodological approach: Researchers should consider a multi-faceted approach:
Prediction using AlphaFold2 or other computational methods
X-ray crystallography of soluble domains (if present)
Cryo-electron microscopy for full-length protein
NMR for dynamic regions
Cross-linking mass spectrometry to identify domain interactions
Structure-function analysis can be performed through systematic mutagenesis of predicted functional motifs, followed by functional assays to determine the impact of specific structural elements.
Post-translational modifications (PTMs) often regulate protein function and may be critical for US14 activity during infection.
Methodological approach: Researchers should identify PTMs through:
Mass spectrometry analysis of purified US14
Site-directed mutagenesis of predicted modification sites
Metabolic labeling approaches for specific modifications
PTM-specific antibodies when available
Particular attention should be paid to phosphorylation, glycosylation, and ubiquitination, as these modifications frequently regulate viral protein function. Temporal analysis of PTMs throughout the infection cycle may reveal regulatory mechanisms.
Novel therapeutic approaches against HCMV are needed, especially given the modest efficacy of existing vaccines. Live attenuated HCMV vaccines based on the Towne strain have shown "moderate efficacy in other clinical settings" , but improvements are still needed.
Methodological approach: To evaluate US14 as a therapeutic target, researchers should:
Determine if antibodies against exposed domains of US14 neutralize viral infectivity
Screen for small molecule inhibitors of US14 function
Assess whether US14-deleted viruses could serve as attenuated vaccine candidates
Evaluate US14 peptides as potential T-cell epitopes for vaccine development
Functional importance and conservation across strains would make US14 a more attractive target. Researchers should compare results with other US region proteins with known therapeutic potential.
Comparative virology approaches may reveal conserved functions and evolutionary relationships.
Methodological approach: Researchers should:
Perform bioinformatic comparisons with other betaherpesviruses
Test functional complementation (can homologs substitute for US14?)
Identify conserved motifs that suggest functional importance
Create chimeric proteins to map functional domains
This comparative approach may uncover fundamental mechanisms shared across viral families and identify unique features of HCMV US14.